Delivery Order SPE2DR25D1053-SPE2DR26FU628
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,491.97 to AmerisourceBergen Drug Corp for the supply of Lumakras 320 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on August 29, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The place...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Lumakras 320 mg tablets (90-unit quantity) with a ceiling value of $14,218.46. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lumakras 320 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $13,491.97. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 13, 2025. The award is issued to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as the place of performance....
- The Defense Logistics Agency awarded a delivery order valued at $14,218.46 to AmerisourceBergen Drug Corp for 90 tablets of Lumakras 320 mg on December 1, 2025, with completion scheduled for December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a pharmaceutical supply delivery to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $13,491.97 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of LUMAKRAS 320 mg tablets (90-unit quantity). This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, with performance to be...
- The Defense Logistics Agency awarded a delivery order valued at $14,218.46 to AmerisourceBergen Drug Corp for LUMAKRAS 320 mg tablets (90-count units) on November 28, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The contract is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,218.46 delivery order to AmerisourceBergen Drug Corp for 90 tablets of LUMAKRAS 320 mg on December 4, 2025, with completion scheduled for December 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- This is a $25,121.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. The company has been...
- This is a $13,491.97 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of June 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX to provide a wide...
- The Defense Logistics Agency awarded a $12,042.19 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 90 LUMAKRAS 320 MG tablets for delivery by November 13, 2023. The place of performance will be in Conshohocken, Pennsylvania. No set-aside designation was used for this award to supply oncology pharmaceutical products in support of the Defense Logistics Agency's mission to provide medical supplies and equipment to...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU628Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Lumakras 320 mg tablets in a quantity of 90 units, with a ceiling value of $14,218.46. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 2, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a pediatric medication delivery within AmerisourceBergen's broader pharmaceutical supply portfolio to federal health systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime contract running through December 2026 that serves as the company's comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen maintains a significant role in the Defense Logistics Agency's medical supply chain, fulfilling orders for specialty medications, branded and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic areas for defense and veteran healthcare systems. The parent IDC demonstrates the company's capability to meet complex federal procurement requirements and serve diverse federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 12/9/25 |